Genetic Testing Services at Nova
At Nova International Diagnostics, we offer an extensive range of genetic disorder testing services, powered by cutting-edge technology and a team of skilled professionals. Our goal is to provide accurate and comprehensive insights into genetic health, enabling informed medical decisions and personalized care.
NIPT (Non-Invasive Prenatal Testing)
Test Description
NIPT is a safe and accurate prenatal screening test that detects common chromosomal abnormalities in the fetus. This non-invasive test helps expectant parents make informed decisions regarding their pregnancy and plan for the well-being of the unborn child.
Methodology
Cell-free DNA analysis using Next-Generation Sequencing (NGS).
Test Features
Early detection of chromosomal abnormalities in the fetus, such as Down syndrome (Trisomy 21), Trisomy 18, Trisomy 13, and others. – Gender determination.
Sample Collection & Submission Process
NIPT requires a simple blood sample from the expectant mother.
Our collection centers are strategically located for convenience, and our team ensures proper sample handling and timely submission to the laboratory.
Pre-implantation Genetic Screening
Test Description
Pre-implantation Genetic Screening (PGS) is a vital test for couples undergoing in-vitro fertilization (IVF). This screening helps identify chromosomal abnormalities in embryos before implantation, reducing the risk of genetic disorders and increasing the chances of successful pregnancies.
Methodology
Next-Generation Sequencing (NGS) of IVF embryos.
Test Features
Screening embryos for chromosomal abnormalities before implantation.
Improving the success rate of IVF procedures.
Sample Collection & Submission Process
The sample for PGS is collected during the IVF process.
Our laboratory collaborates closely with fertility clinics to ensure seamless sample submission and timely reporting of results.
Breast Cancer Screening
Test Description
Nova’s Breast Cancer Screening test is a specialized screening for early detection and risk assessment of breast cancer. It aids in identifying specific genetic mutations related to breast cancer, allowing for early intervention and personalized treatment strategies.
Methodology
Next-Generation Sequencing (NGS).
Test Features
Early detection of germline mutations associated with breast cancer.
Assessing the risk of developing breast cancer.
Somatic mutation analysis of biopsy specimens.
Sample Collection & Submission Process
Sample collection typically involves a blood draw for germline mutations.
Somatic mutations analysis requires biopsy specimens or tissue blocks.
Our laboratory ensures a smooth and efficient sample submission process, providing detailed instructions for sample handling and transportation.
Cancer Hot Spot Gene Panels
Test Description
Nova’s Cancer Hot Spot Gene Panels focus on detecting 50 different genes associated mutations commonly found in various cancers. By identifying these mutations, our test helps oncologists tailor targeted therapies for improved treatment outcomes and patient care.
Methodology
Next-Generation Sequencing (NGS).
Test Features
Identifying specific genetic mutations in cancer cells.
Guiding oncologists in selecting targeted therapies.
Sample Collection & Submission Process
Sample collection involves blood or tissue samples, depending on the specific test.
Our laboratory team provides clear instructions on sample collection and submission, ensuring accurate and timely results.
Once the samples are collected, they are carefully handled and processed in our state-of-the-art laboratory. Our team works diligently to provide accurate and timely results to healthcare providers, enabling them to offer the best possible care to their patients.
At Nova International Diagnostics, we are dedicated to advancing genetic testing services, bringing precision and innovation to the forefront of healthcare for a healthier future.